XBiotech Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2013 to 2023

Taxonomy & unit: us-gaap: USD
Description: The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary: XBiotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
XBiotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$13M, a 48.8% decline year-over-year.
XBiotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$35M, a 23.2% decline year-over-year.
XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$24.6M, a 25.4% increase from 2022.
XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.9M, a 88.9% decline from 2021.
XBiotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.4M, a 55.2% decline from 2020.

Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)

Net Income (Loss) Attributable to Parent, Annual (USD)

Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$24.6M	+$8.34M	+25.4%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-15
2022	-$32.9M	-$15.5M	-88.9%	Jan 1, 2022	Dec 31, 2022	10-K	2024-03-15
2021	-$17.4M	-$6.19M	-55.2%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-15
2020	-$11.2M	-$680M	-102%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-15
2019	$669M	+$690M		Jan 1, 2019	Dec 31, 2019	10-K	2022-03-15
2018	-$21.1M	+$12M	+36.2%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-16
2017	-$33.2M	+$19.6M	+37.2%	Jan 1, 2017	Dec 31, 2017	10-K	2020-03-16
2016	-$52.8M	-$15.3M	-40.8%	Jan 1, 2016	Dec 31, 2016	10-K/A	2019-03-15
2015	-$37.5M	-$15.8M	-72.5%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-16
2014	-$21.7M	-$11.8M	-119%	Jan 1, 2014	Dec 31, 2014	10-K	2017-03-16
2013	-$9.93M			Jan 1, 2013	Dec 31, 2013	10-K/A	2016-04-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.